Endogun’s product is aimed at offering a single-incision, simpler and safer procedure, which is performed entirely trans-vaginally.
Elad Naggar, chairman of the board, Endogun, said: “The FDA approval for our single use, disposable EndoFast Reliant product is a key milestone towards bringing Endogun’s products to the prolapse and stress urinary incontinence markets.”